AirSeal is selected as a recipient of the first WashU Venture Network Follow-on Investments

https://www.linkedin.com/posts/arch-grants_stlmade-championthebold-2022cohort-activity- utm_source=share&utm_medium=member_desktop&rcm=ACoAAE3ILu4BTUGr_Y8qvvLgjbd2F6ZmYMFnz0

Our co-founder, Dr. Zayed, was recently interviewed by KMOX Radio discussing our innovative PADGuard blood test. During the interview, Dr. Zayed explained how this breakthrough technology will transform the diagnosis and care of patients with Peripheral Arterial Disease by enabling earlier detection and more personalized treatment plans.

https://lnkd.in/eQiudG4A

AirSeal is awarded a co-investment of $500,000 from Missouri Technology Corporation (MTC)

https://www.missouritechnology.com/2024/11/05/mtc-awards-2-55-million-in-the-october-2024-investment-cycle/

AirSeal is selected as a 2024 Arch Grants recipient, which includes a $75,000 non-dilutive cash award.

https://olin.wustl.edu/about/news-and-media/news/2024/12/olin-emba-alums-arch-grants-healthcare-startups.php

AirSeal CardioVascular wins the 2024 Global Impact Award from WashU Skandalaris Center

https://skandalaris.wustl.edu/blog/2024/04/18/an-unprecedented-night-at-the-innovation-entrepreneurship-awards/

https://skandalaris.wustl.edu/sc-programs/global-impact-award/

AirSeal CardioVascular and Dr. Zayed is highlighted in St. Louis Magazine as ‘Ones to Watch: St. Louisans driving disruption in a range of industries’ and TMC blog page

https://www.stlmag.com/business/st-louisans-driving-disruption-range-industries/

https://www.tmc.edu/blog/unveiling-progress-latest-developments-from-tmcis-accelerator-for-healthtech-cohort/

Richard Clark joins AirSeal as a general manager and CEO. Richard is a seasoned entrepreneur with 2 previous exits and brings over 40 years of business experience in health tech and pharmaceutical industry to AirSeal.  He is a member of the EXECUTIVE IN RESIDENCE program of BioGenerator. Welcome Richard!

https://www.biogeneratorventures.com/team?detail=367

AirSeal is selected as one of the seven companies to be part of TMC Innovation Healthtech Accelerator Cohort 17. We are leveraging resources and advices from TMC to further collaborations and commercialization efforts

https://www.tmc.edu/blog/tmc-innovation-factory-hosts-cohort-17-for-its-healthtech-accelorator-bootcamp/

AirSeal is one of the ten teams (selected from hundreds of global applicants) to attend the TMCi Healthtech Accelerator Bootcamp. We are excited to meet other venture teams and TMCi advisors.

https://www.tmc.edu/blog/tmc-innovation-factory-hosts-cohort-17-for-its-healthtech-accelorator-bootcamp/

AirSeal wins a co-investment award of $100,000 from Missouri Technology Corporation.

https://www.missouritechnology.com/2023/11/09/mtc-awards-2-4-million-in-the-october-2023-investment-cycle/

AirSeal is one of the finalists competing for the Arch Grants 2023.

AirSeal wins the prestigious TMC Venture Healthcare Investment Prize of $250,000 and the Elevator Pitch at Biotech/Health Care sector from the Rice Business Plan Competition (RBPC23). 

https://youtu.be/RKXMWEX2df8

https://www.linkedin.com/posts/tmcinnovation_rbpc2023-activity-7064787413021192192-rw8Q?utm_source=share&utm_medium=member_desktop

https://skandalaris.wustl.edu/blog/2023/05/22/airseal-wins-250k-tmc-innovation-healthcare-investment-prize-at-rice-business-plan-competition/

AirSeal is one of the six finalists of the Global Impact Award (GIA) competition held by the Skandalaris Center of Washington University.

https://skandalaris.wustl.edu/blog/2023/01/30/skandalaris-announces-six-finalists-for-the-2023-global-impact-award/ 

AirSeal is one of semi-finalists of the TigerLaunch competition held by Princeton University.